{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:13:45Z","timestamp":1791918825963,"version":"4.3.4"},"reference-count":149,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["NANOTEC"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Fungal infections are becoming one of the most common diseases in recent years, especially\nwhen it comes about dealing skin infections. Different drugs are available commercially with antifungal\nactivity for topical application and are effective for treatment of mild to moderate fungal infections.\nHowever they lack dermal bioavailability due to their poor penetrability, and less retention at the site\nthereby resulting in poor efficacy. The remaining systemic treatment options available so far may cause\nadverse drug effects and many other complications. In recent years nano carrier based formulations\npromised to overcome the limitations of the conventional topical dosage forms. Lipid based nano carriers\nand their importance for potential use in delivery of antifungal agents for the treatment of superficial\nfungal infections have been well discussed in this review article. It comprises of different nano lipid\nsystems involved in treatment of topical fungal infections, effect of different polymers on their size, stability,\nand their mechanistic action behind skin penetration and dermal retention of drug into deeper epidermal\nlayers is also highlighted to depict recent efforts of researchers in this context. Further, addressing\nof the disease by novel drug delivery systems for the efficacious treatment, status of clinical trials,\nnovel commercial formulations available for use in dermal drug delivery and patents claimed\/granted in\nthe respective fields have been discussed in detail.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1872210517666230727090314","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T09:45:05Z","timestamp":1690451105000},"page":"183-204","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Recent Progression in Nanocarrier based Techniques to Address Fungal Infections and Patent Status in Drug Development Process"],"prefix":"10.2174","volume":"19","author":[{"given":"Ravi Pratap","family":"Singh","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, ISF College of Pharmacy, Moga, 142 001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj Kumar","family":"Narang","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, ISF College of Pharmacy, Moga, 142 001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrinder","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, ISF College of Pharmacy, Moga, 142 001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1208\/s12249-022-02357-y","volume":"23","author":"Mosallam S.","year":"2022","unstructured":"Mosallam S.; Albash R.; Abdelbari M.A.; Advanced vesicular systems for antifungal drug delivery. AAPS PharmSciTech  2022,23(6),206","journal-title":"AAPS PharmSciTech"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.biopha.2018.04.061","volume":"103","author":"Abrigach F.","year":"2018","unstructured":"Abrigach F.; Rokni Y.; Takfaoui A.; In vitro screening, homology modeling and molecular docking studies of some pyrazole and imidazole derivatives. Biomed Pharmacother  2018,103,653-661","journal-title":"Biomed Pharmacother"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.18502\/cmm.7.1.6247","volume":"7","author":"Asadi P.","year":"2021","unstructured":"Asadi P.; Mehravaran A.; Soltanloo N.; Abastabar M.; Akhtari J.; Nanoliposome-loaded antifungal drugs for dermal administration: A review. Curr Med Mycol  2021,7(1),71-78","journal-title":"Curr Med Mycol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1159\/000511038","volume":"33","author":"Lengert E.V.","year":"2020","unstructured":"Lengert E.V.; Talnikova E.E.; Tuchin V.V.; Svenskaya Y.I.; Prospective nanotechnology-based strategies for enhanced intra- and transdermal delivery of antifungal drugs. Skin Pharmacol Physiol  2020,33(5),261-269","journal-title":"Skin Pharmacol Physiol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.7324\/JAPS.2021.11s102","volume":"11","author":"Manju N.","year":"2021","unstructured":"Manju N.; Malkiet K.; Nanomaterials for skin antifungal therapy: An updated review. J Appl Pharm Sci  2021,11(1),15-25","journal-title":"J Appl Pharm Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"102397","DOI":"10.1016\/j.jddst.2021.102397","volume":"62","author":"Nene S.","year":"2021","unstructured":"Nene S.; Shah S.; Rangaraj N.; Mehra N.K.; Singh P.K.; Srivastava S.; Lipid based nanocarriers: A novel paradigm for topical antifungal therapy. J Drug Deliv Sci Technol  2021,62,102397","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3390\/jof7080629","volume":"7","author":"Martinez-Rossi N.M.","year":"2021","unstructured":"Martinez-Rossi N.M.; Peres N.T.A.; Bitencourt T.A.; Martins M.P.; Rossi A.; State-of-the-art dermatophyte infections: Epidemiology aspects, pathophysiology, and resistance mechanisms. J Fungi  2021,7(8),629","journal-title":"J Fungi"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1439-0507.2011.02081.x","volume":"55","author":"Baldo A.","year":"2012","unstructured":"Baldo A.; Monod M.; Mathy A.; Mechanisms of skin adherence and invasion by dermatophytes. Mycoses  2012,55(3),218-223","journal-title":"Mycoses"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11046-008-9104-5","volume":"166","author":"Vermout S.","year":"2008","unstructured":"Vermout S.; Tabart J.; Baldo A.; Mathy A.; Losson B.; Mignon B.; Pathogenesis of dermatophytosis. Mycopathologia  2008,166(5-6),267-275","journal-title":"Mycopathologia"},{"key":"ref=10","unstructured":"USFDA.  Available from:  https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/214900s000lbl.pdf (accessed 18-11-2022)."},{"key":"ref=11","unstructured":"Isavuconazonium. USFDA. Available from:  https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/207500s008,207501s007lbl.pdf (accessed 18-11-2022)."},{"key":"ref=12","year":"2014","unstructured":"Efinaconazole. USFDA Available from:  https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/203567s000lbl.pdf (accessed 18-11-2022).2014"},{"key":"ref=13","year":"2014","unstructured":"Tavaborale. USFDA Available from:  https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/204427s006lbl.pdf (acessed 11-01-2023).2014"},{"key":"ref=14","unstructured":"USFDA Tolsura Available from:  https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2018\/208901Orig1s000Approv.pdf (acessed 11-01-2023)."},{"key":"ref=15","unstructured":"Available from:  accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/021266s039,021267s050,021630s029lbl.pdf (acessed 11-01-2023)."},{"key":"ref=16","unstructured":"FDA internet application site.  Available from:  https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/022003s018s020,0205053s002s004,0205596s001s003lbl.pdf (acessed 11-01-2023)."},{"key":"ref=17","year":"2022","unstructured":"VIVJOA\u2122 (oteseconazole) capsules, for oral use Initial U.S. Approval.  Available from:  https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/215888s000lbl.pdf (acessed 11-01-2023).2022"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3109\/17453054.2010.525439","volume":"33","author":"Swann G.","year":"2010","unstructured":"Swann G.; Editorial. J Vis Commun Med  2010,33(4),148-149","journal-title":"J Vis Commun Med"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41587-019-0079-1","volume":"37","author":"Someya T.","year":"2019","unstructured":"Someya T.; Amagai M.; Toward a new generation of smart skins. Nat Biotechnol  2019,37(4),382-388","journal-title":"Nat Biotechnol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.mpsur.2010.07.011","volume":"28","author":"Venus M.","year":"2010","unstructured":"Venus M.; Waterman J.; McNab I.; Basic physiology of the skin. Surgery  2010,28(10),469-472","journal-title":"Surgery"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3390\/nu11020249","volume":"11","author":"Bragazzi N.","year":"2019","unstructured":"Bragazzi N.; Sellami M.; Salem I.; Fasting and its impact on skin anatomy, physiology, and physiopathology: A comprehensive review of the literature. Nutrients  2019,11(2),249","journal-title":"Nutrients"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/bies.950171213","volume":"17","author":"Bangham A.D.","year":"1995","unstructured":"Bangham A.D.; Surrogate cells or trojan horses. The discovery of liposomes. BioEssays  1995,17(12),1081-1088","journal-title":"BioEssays"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.2042-7158.1982.tb04767.x","volume":"34","author":"Mezei M.","year":"2011","unstructured":"Mezei M.; Gulasekharam V.; Liposomes\u2014A selective drug delivery system for the topical route of administration: Gel dosage form. J Pharm Pharmacol  2011,34(7),473-474","journal-title":"J Pharm Pharmacol"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1567201820666221207140956","volume":"20","author":"Sharma Y.","year":"2023","unstructured":"Sharma Y.; Patel P.; Kurmi B.D.; A mini-review on new developments in nanocarriers and polymers for ophthalmic drug delivery strategies. Curr Drug Deliv  2023,20,1-21","journal-title":"Curr Drug Deliv"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.colsurfb.2014.05.030","volume":"121","author":"Alomrani A.H.","year":"2014","unstructured":"Alomrani A.H.; Shazly G.A.; Amara A.A.; Badran M.M.; Itraconazole-hydroxypropyl-\u03b2-cyclodextrin loaded deformable liposomes: In vitro skin penetration studies and antifungal efficacy using Candida albicans as model. Colloids Surf B Biointerfaces  2014,121,74-81","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3109\/08982104.2013.871025","volume":"24","author":"Pandit J.","year":"2014","unstructured":"Pandit J.; Garg M.; Jain N.K.; Miconazole nitrate bearing ultraflexible liposomes for the treatment of fungal infection. J Liposome Res  2014,24(2),163-169","journal-title":"J Liposome Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ejpb.2004.09.006","volume":"59","author":"Alsarra I.A.","year":"2005","unstructured":"Alsarra I.A.; Bosela A.A.; Ahmed S.M.; Mahrous G.M.; Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur J Pharm Biopharm  2005,59(3),485-490","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3109\/10717544.2013.838077","volume":"21","author":"Abdelkader H.","year":"2014","unstructured":"Abdelkader H.; Alani A.W.G.; Alany R.G.; Recent advances in non-ionic surfactant vesicles (niosomes): Self-assembly, fabrication, characterization, drug delivery applications and limitations. Drug Deliv  2014,21(2),87-100","journal-title":"Drug Deliv"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jconrel.2016.09.008","volume":"242","author":"Ashtikar M.","year":"2016","unstructured":"Ashtikar M.; Nagarsekar K.; Fahr A.; Transdermal delivery from liposomal formulations: Evolution of the technology over the last three decades. J Control Release  2016,242,126-140","journal-title":"J Control Release"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1023\/A:1018963910260","volume":"11","author":"Hofland H.E.J.","year":"1994","unstructured":"Hofland H.E.J.; van der Geest R.; Bodde H.E.; Junginger H.E.; Bouwstra J.A.; Estradiol permeation from nonionic surfactant vesicles through human stratum corneum in vitro. Pharm Res  1994,11(5),659-664","journal-title":"Pharm Res"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1248\/cpb.34.3415","volume":"34","author":"Komatsu H.","year":"1986","unstructured":"Komatsu H.; Higaki K.; Okamoto H.; Miyagawa K.; Hashida M.; Sezaki H.; Preservative activity and in vivo percutaneous penetration of butylparaben entrapped in liposomes. Chem Pharm Bull  1986,34(8),3415-3422","journal-title":"Chem Pharm Bull"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/jid.2012.461","volume":"133","author":"Brewer J.","year":"2013","unstructured":"Brewer J.; Bloksgaard M.; Kubiak J.; S\u00f8rensen J.A.; Bagatolli L.A.; Spatially resolved two-color diffusion measurements in human skin applied to transdermal liposome penetration. J Invest Dermatol  2013,133(5),1260-1268","journal-title":"J Invest Dermatol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1211\/jpp.58.4.0001","volume":"58","author":"El Maghraby G.M.M.","year":"2010","unstructured":"El Maghraby G.M.M.; Williams A.C.; Barry B.W.; Can drug-bearing liposomes penetrate intact skin? J Pharm Pharmacol  2010,58(4),415-429","journal-title":"J Pharm Pharmacol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0378-5173(84)90225-4","volume":"20","author":"Ganesan M.G.","year":"1984","unstructured":"Ganesan M.G.; Weiner N.D.; Flynn G.L.; Ho N.F.H.; Influence of liposomal drug entrapment on percutaneous absorption. Int J Pharm  1984,20(1-2),139-154","journal-title":"Int J Pharm"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.2042-7158.1987.tb03407.x","volume":"39","author":"Kato A.","year":"2011","unstructured":"Kato A.; Ishibashi Y.; Miyake Y.; Effect of egg yolk lecithin on transdermal delivery of bunazosin hydrochloride. J Pharm Pharmacol  2011,39(5),399-400","journal-title":"J Pharm Pharmacol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cis.2013.11.018","volume":"205","author":"Marianecci C.","year":"2014","unstructured":"Marianecci C.; Di Marzio L.; Rinaldi F.; Niosomes from 80s to present: The state of the art. Adv Colloid Interface Sci  2014,205,187-206","journal-title":"Adv Colloid Interface Sci"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ajps.2018.05.007","volume":"14","author":"Verma S.","year":"2019","unstructured":"Verma S.; Utreja P.; Vesicular nanocarrier based treatment of skin fungal infections: Potential and emerging trends in nanoscale pharmacotherapy. Asian J Pharm Sci  2019,14(2),117-129","journal-title":"Asian J Pharm Sci"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejpb.2019.08.015","volume":"144","author":"Chen S.","year":"2019","unstructured":"Chen S.; Hanning S.; Falconer J.; Locke M.; Wen J.; Recent advances in non-ionic surfactant vesicles (niosomes): Fabrication, characterization, pharmaceutical and cosmetic applications. Eur J Pharm Biopharm  2019,144,18-39","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3109\/10717544.2013.841783","volume":"21","author":"Yasam V.R.","year":"2014","unstructured":"Yasam V.R.; Jakki S.L.; Natarajan J.; Kuppusamy G.; A review on novel vesicular drug delivery: Proniosomes. Drug Deliv  2014,21(4),243-249","journal-title":"Drug Deliv"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"56","DOI":"10.5530\/ijpi.2021.1.11","volume":"11","author":"Mahajan S.S.","year":"2021","unstructured":"Mahajan S.S.; RY Chaudhari C.; VR Patil P.; Formulation and evaluation of topical proniosomal gel of ciclopirox for antifungal therapy. Int J Pharm Investig  2021,11(1),56-62","journal-title":"Int J Pharm Investig"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0168-3659(97)00100-4","volume":"54","author":"Vora B.","year":"1998","unstructured":"Vora B.; Khopade A.J.; Jain N.K.; Proniosome based transdermal delivery of levonorgestrel for effective contraception. J Control Release  1998,54(2),149-165","journal-title":"J Control Release"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/0005-2736(92)90154-E","volume":"1104","author":"Cevc G.","year":"1992","unstructured":"Cevc G.; Blume G.; Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta Biomembr  1992,1104(1),226-232","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"606","DOI":"10.2174\/0929867324666171009120154","volume":"25","author":"Carita A.C.","year":"2018","unstructured":"Carita A.C.; Eloy J.O.; Chorilli M.; Lee R.J.; Leonardi G.R.; Recent advances and perspectives in liposomes for cutaneous drug delivery. Curr Med Chem  2018,25(5),606-635","journal-title":"Curr Med Chem"},{"key":"ref=44","first-page":"103","author":"Das B.","year":"2022","unstructured":"Das B.; Nayak A.K.; Mallick S.;  In: Systems of Nanovesicular Drug Delivery  2022,103-114","journal-title":"In: Systems of Nanovesicular Drug Delivery"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3390\/pharmaceutics12090855","volume":"12","author":"Opatha S.A.T.","year":"2020","unstructured":"Opatha S.A.T.; Titapiwatanakun V.; Chutoprapat R.; Transfersomes: A promising nanoencapsulation technique for transdermal drug delivery. Pharmaceutics  2020,12(9),855","journal-title":"Pharmaceutics"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2017.05.029","volume":"527","author":"Abdellatif M.M.","year":"2017","unstructured":"Abdellatif M.M.; Khalil I.A.; Khalil M.A.F.; Sertaconazole nitrate loaded nanovesicular systems for targeting skin fungal infection: In vitro, ex vivo and in vivo evaluation. Int J Pharm  2017,527(1-2),1-11","journal-title":"Int J Pharm"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0168-3659(99)00222-9","volume":"65","author":"Touitou E.","year":"2000","unstructured":"Touitou E.; Dayan N.; Bergelson L.; Godin B.; Eliaz M.; Ethosomes: Novel vesicular carriers for enhanced delivery: Characterization and skin penetration properties. J Control Release  2000,65(3),403-418","journal-title":"J Control Release"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1517\/17425240903071029","volume":"6","author":"Sinico C.","year":"2009","unstructured":"Sinico C.; Fadda A.M.; Vesicular carriers for dermal drug delivery. Expert Opin Drug Deliv  2009,6(8),813-825","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.xphs.2016.10.001","volume":"106","author":"Jain S.","year":"2017","unstructured":"Jain S.; Patel N.; Shah M.K.; Khatri P.; Vora N.; Recent advances in lipid-based vesicles and particulate carriers for topical and transdermal application. J Pharm Sci  2017,106(2),423-445","journal-title":"J Pharm Sci"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.2147\/IJN.S105016","volume":"11","author":"Abdulbaqi I.M.","year":"2016","unstructured":"Abdulbaqi I.M.; Darwis Y.; Khan N.A.; Assi R.A.; Khan A.A.; Ethosomal nanocarriers: The impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials. Int J Nanomedicine  2016,11,2279-2304","journal-title":"Int J Nanomedicine"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"39","DOI":"10.20902\/IJCTR.2019.120505","volume":"12","author":"Rao B.N.","year":"2019","unstructured":"Rao B.N.; Reddy K.R.; Mounika B.; Fathima S.R.; Tejaswini A.; Vesicular drug delivery system: A review. Int J Chemtech Res  2019,12(5),39-53","journal-title":"Int J Chemtech Res"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"102280","DOI":"10.1016\/j.jddst.2020.102280","volume":"61","author":"Hajare A.","year":"2021","unstructured":"Hajare A.; Dol H.; Patil K.; Design and development of terbinafine hydrochloride ethosomal gel for enhancement of transdermal delivery: In vitro, in vivo, molecular docking, and stability study. J Drug Deliv Sci Technol  2021,61,102280","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/1440-1681.13623","volume":"49","author":"Lin B.","year":"2022","unstructured":"Lin B.; Wang W.; Ba W.; Li H.; Fan J.; Preparation and partial pharmacodynamic studies of luliconazole ethosomes. Clin Exp Pharmacol Physiol  2022,49(5),549-557","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s13205-020-2083-z","volume":"10","author":"Dave V","year":"2020","unstructured":"Dave V; Bhardwaj N; Gupta N; Tak K; Herbal ethosomal gel containing luliconazole for productive relevance in the field of biomedicine. 3 Biotech  2020,10(3),97","journal-title":"3 Biotech"},{"key":"ref=55","first-page":"2681","volume":"9","author":"Shaji J.","year":"2018","unstructured":"Shaji J.; In Transethosomes: A new prospect for enhanced transdermal delivery. Int J Pharm Sci  2018,9(7),2681-2685","journal-title":"Int J Pharm Sci"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5530\/ijper.55.1s.33","volume":"55","author":"Bajaj K.J.","year":"2021","unstructured":"Bajaj K.J.; Parab B.S.; Shidhaye S.S.; Nano-transethosomes: A novel tool for drug delivery through skin. Indian J Pharm Educ Res  2021,55,1-10","journal-title":"Indian J Pharm Educ Res"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"102998","DOI":"10.1016\/j.jddst.2021.102998","volume":"67","author":"Mishra K.K.","year":"2022","unstructured":"Mishra K.K.; Kaur C.D.; Gupta A.; Development of itraconazole loaded ultra-deformable transethosomes containing oleic-acid for effective treatment of dermatophytosis: Box-Behnken design, ex vivo and in vivo studies. J Drug Deliv Sci Technol  2022,67,102998","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2174\/2211738506666180813122102","volume":"6","author":"Verma S.","year":"2018","unstructured":"Verma S.; Utreja P.; Transethosomes of econazole nitrate for transdermal delivery: Development, in vitro characterization, and ex vivo assessment. Pharm Nanotechnol  2018,6(3),171-179","journal-title":"Pharm Nanotechnol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/pharmaceutics13020151","volume":"13","author":"Ahmed T.A.","year":"2021","unstructured":"Ahmed T.A.; Alzahrani M.M.; Sirwi A.; Alhakamy N.A.; Study the antifungal and ocular permeation of ketoconazole from ophthalmic formulations containing trans-ethosomes nanoparticles. Pharmaceutics  2021,13(2),151","journal-title":"Pharmaceutics"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4103\/0975-8453.86290","volume":"2","author":"Patel D.M.","year":"2011","unstructured":"Patel D.M.; Patel C.N.; Jani R.H.; Ufasomes: A vesicular drug delivery. Sys Rev Pharm  2011,2(2),72-78","journal-title":"Sys Rev Pharm"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s43094-020-00143-w","volume":"7","author":"Bhattacharya S.","year":"2021","unstructured":"Bhattacharya S.; Preparation and characterizations of glyceryl oleate ufasomes of terbinafine hydrochloride: A novel approach to trigger Candida albicans fungal infection. Future J Pharm Sci  2021,7(1),3","journal-title":"Future J Pharm Sci"},{"key":"ref=62","first-page":"1","volume":"7","author":"Khalifa M.K.A.","year":"2015","unstructured":"Khalifa M.K.A.; Miconazole Nitrate based cubosome hydrogels for topical application. Int J Drug Deliv  2015,7,1-12","journal-title":"Int J Drug Deliv"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jcis.2009.03.054","volume":"336","author":"Alam M.M.","year":"2009","unstructured":"Alam M.M.; Aramaki K.; Effect of molecular weight of triglycerides on the formation and rheological behavior of cubic and hexagonal phase based gel emulsions. J Colloid Interface Sci  2009,336(1),329-334","journal-title":"J Colloid Interface Sci"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ijpharm.2008.08.022","volume":"365","author":"Lee K.","year":"2009","unstructured":"Lee K.; Nguyen T.; Hanley T.; Boyd B.; Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs. Int J Pharm  2009,365(1-2),190-199","journal-title":"Int J Pharm"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1002\/jps.20808","volume":"96","author":"Rosenblatt K.M.","year":"2007","unstructured":"Rosenblatt K.M.; Douroumis D.; Bunjes H.; Drug release from differently structured monoolein\/poloxamer nanodispersions studied with differential pulse polarography and ultrafiltration at low pressure. J Pharm Sci  2007,96(6),1564-1575","journal-title":"J Pharm Sci"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","volume":"382","author":"Cao B.","year":"2020","unstructured":"Cao B.; Wang Y.; Wen D.; A trial of lopinavir\u2013ritonavir in adults hospitalized with severe COVID-19. N Engl J Med  2020,382(19),1787-1799","journal-title":"N Engl J Med"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"361","DOI":"10.5650\/jos.58.361","volume":"58","author":"Alam M.M.","year":"2009","unstructured":"Alam M.M.; Ushiyama K.; Aramaki K.; Phase behavior, formation, and rheology of cubic phase and related gel emulsion in Tween 80\/water\/oil systems. J Oleo Sci  2009,58(7),361-367","journal-title":"J Oleo Sci"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"6290","DOI":"10.2174\/1381612811319350006","volume":"19","author":"Pan X.","year":"2013","unstructured":"Pan X.; Han K.; Peng X.; Nanostructured cubosomes as advanced drug delivery system. Curr Pharm Des  2013,19(35),6290-6297","journal-title":"Curr Pharm Des"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"111548","DOI":"10.1016\/j.msec.2020.111548","volume":"119","author":"Rapalli V.K.","year":"2021","unstructured":"Rapalli V.K.; Banerjee S.; Khan S.; QbD-driven formulation development and evaluation of topical hydrogel containing ketoconazole loaded cubosomes. Mater Sci Eng C  2021,119,111548","journal-title":"Mater Sci Eng C"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijpharm.2010.12.036","volume":"406","author":"Kovacevic A.","year":"2011","unstructured":"Kovacevic A.; Savic S.; Vuleta G.; M\u00fcller R.H.; Keck C.M.; Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): Effects on size, physical stability and particle matrix structure. Int J Pharm  2011,406(1-2),163-172","journal-title":"Int J Pharm"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/978-3-642-19792-5_5","author":"Guimar\u00e3es K.L.","year":"2011","unstructured":"Guimar\u00e3es K.L.; R\u00e9 M.I.;  Nanocosmetics and Nanomedicines: New Approaches for Skin Care  2011,101-122","journal-title":"Nanocosmetics and Nanomedicines: New Approaches for Skin Care"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2174\/157016311796799062","volume":"8","author":"M\u00fcller R.H.","year":"2011","unstructured":"M\u00fcller R.H.; Shegokar R.; Keck C.M.; 20 years of lipid nanoparticles (SLN and NLC): Present state of development and industrial applications. Curr Drug Discov Technol  2011,8(3),207-227","journal-title":"Curr Drug Discov Technol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1517\/17425247.2012.673278","volume":"9","author":"Battaglia L.","year":"2012","unstructured":"Battaglia L.; Gallarate M.; Lipid nanoparticles: State of the art, new preparation methods and challenges in drug delivery. Expert Opin Drug Deliv  2012,9(5),497-508","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/801820","volume":"2014","author":"Shrestha H.","year":"2014","unstructured":"Shrestha H.; Bala R.; Arora S.; Lipid-based drug delivery systems. J Pharm  2014,2014,1-10","journal-title":"J Pharm"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.biopha.2018.04.055","volume":"103","author":"Khosa A.","year":"2018","unstructured":"Khosa A.; Reddi S.; Saha R.N.; Nanostructured lipid carriers for site-specific drug delivery. Biomed Pharmacother  2018,103,598-613","journal-title":"Biomed Pharmacother"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ijpharm.2008.10.003","volume":"366","author":"Pardeike J.","year":"2009","unstructured":"Pardeike J.; Hommoss A.; M\u00fcller R.H.; Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm  2009,366(1-2),170-184","journal-title":"Int J Pharm"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1089\/jop.2012.0128","volume":"29","author":"del Pozo-Rodr\u00edguez A.","year":"2013","unstructured":"del Pozo-Rodr\u00edguez A.; Delgado D.; Gasc\u00f3n A.R.; Solin\u00eds M.\u00c1.; Lipid nanoparticles as drug\/gene delivery systems to the retina. J Ocul Pharmacol Ther  2013,29(2),173-188","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"305","DOI":"10.15171\/apb.2015.043","volume":"5","author":"Naseri N.","year":"2015","unstructured":"Naseri N.; Valizadeh H.; Zakeri-Milani P.; Solid lipid nanoparticles and nanostructured lipid carriers: Structure, preparation and application. Adv Pharm Bull  2015,5(3),305-313","journal-title":"Adv Pharm Bull"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"6684","DOI":"10.2174\/1381612823666171115112745","volume":"23","author":"Gratieri T.","year":"2017","unstructured":"Gratieri T.; Krawczyk-Santos A.P.; da Rocha P.B.R.; SLN- and NLC-encapsulating antifungal agents: Skin drug delivery and their unexplored potential for treating onychomycosis. Curr Pharm Des  2017,23(43),6684-6695","journal-title":"Curr Pharm Des"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1080\/03639045.2020.1752707","volume":"46","author":"Mahmoud R.A.","year":"2020","unstructured":"Mahmoud R.A.; Hussein A.K.; Nasef G.A.; Mansour H.F.; Oxiconazole nitrate solid lipid nanoparticles: Formulation, in vitro characterization and clinical assessment of an analogous loaded carbopol gel. Drug Dev Ind Pharm  2020,46(5),706-716","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1080\/03639045.2020.1871005","volume":"47","author":"Elkomy M.H.","year":"2021","unstructured":"Elkomy M.H.; Elmowafy M.; Shalaby K.; Development and machine-learning optimization of mucoadhesive nanostructured lipid carriers loaded with fluconazole for treatment of oral candidiasis. Drug Dev Ind Pharm  2021,47(2),246-258","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ejpb.2018.10.017","volume":"133","author":"Gordillo-Galeano A.","year":"2018","unstructured":"Gordillo-Galeano A.; Mora-Huertas C.E.; Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release. Eur J Pharm Biopharm  2018,133,285-308","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2147\/TCRM.S40160","volume":"10","author":"Yapar N.","year":"2014","unstructured":"Yapar N.; Epidemiology and risk factors for invasive candidiasis. Ther Clin Risk Manag  2014,10,95-105","journal-title":"Ther Clin Risk Manag"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/0166-6622(81)80064-9","volume":"3","author":"Danielsson I.","year":"1981","unstructured":"Danielsson I.; Lindman B.; The definition of microemulsion. Colloids Surf  1981,3(4),391-392","journal-title":"Colloids Surf"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0021-9797(69)90357-9","volume":"29","author":"Friberg S.","year":"1969","unstructured":"Friberg S.; Mandell L.; Larsson M.; Mesomorphous phases, a factor of importance for the properties of emulsions. J Colloid Interface Sci  1969,29(1),155-156","journal-title":"J Colloid Interface Sci"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0001-8686(96)00293-X","volume":"65","author":"Sj\u00f6blom J.","year":"1996","unstructured":"Sj\u00f6blom J.; Lindberg R.; Friberg S.E.; Microemulsions: Phase equilibria characterization, structures, applications and chemical reactions. Adv Colloid Interface Sci  1996,65,125-287","journal-title":"Adv Colloid Interface Sci"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jconrel.2016.09.017","volume":"241","author":"Alexander A.","year":"2016","unstructured":"Alexander A.; Patel R.J.; Saraf S.; Saraf S.; Recent expansion of pharmaceutical nanotechnologies and targeting strategies in the field of phytopharmaceuticals for the delivery of herbal extracts and bioactives. J Control Release  2016,241,110-124","journal-title":"J Control Release"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1021\/la00074a001","volume":"3","author":"Shinoda K.","year":"1987","unstructured":"Shinoda K.; Lindman B.; Organized surfactant systems: Microemulsions. Langmuir  1987,3(2),135-149","journal-title":"Langmuir"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/281060b0","volume":"281","author":"Lagourette B.","year":"1979","unstructured":"Lagourette B.; Peyrelasse J.; Boned C.; Clausse M.; Percolative conduction in microemulsion type systems. Nature  1979,281(5726),60-62","journal-title":"Nature"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/17425247.2018.1471058","volume":"15","author":"Agrawal M.","year":"2018","unstructured":"Agrawal M.; Saraf S.; Saraf S.; Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region. Expert Opin Drug Deliv  2018,15(6),589-617","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jcis.2016.03.064","volume":"473","author":"Chiappisi L.","year":"2016","unstructured":"Chiappisi L.; Noirez L.; Gradzielski M.; A journey through the phase diagram of a pharmaceutically relevant microemulsion system. J Colloid Interface Sci  2016,473,52-59","journal-title":"J Colloid Interface Sci"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ejpb.2017.04.007","volume":"117","author":"Shah R.M.","year":"2017","unstructured":"Shah R.M.; Eldridge D.S.; Palombo E.A.; Harding I.H.; Microwave-assisted microemulsion technique for production of miconazole nitrate- and econazole nitrate-loaded solid lipid nanoparticles. Eur J Pharm Biopharm  2017,117,141-150","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.cocis.2007.10.006","volume":"13","author":"Gradzielski M.","year":"2008","unstructured":"Gradzielski M.; Recent developments in the characterisation of microemulsions. Curr Opin Colloid Interface Sci  2008,13(4),263-269","journal-title":"Curr Opin Colloid Interface Sci"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S1359-0294(03)00019-0","volume":"8","author":"L\u00f3pez-Quintela M.A.","year":"2003","unstructured":"L\u00f3pez-Quintela M.A.; Synthesis of nanomaterials in microemulsions: Formation mechanisms and growth control. Curr Opin Colloid Interface Sci  2003,8(2),137-144","journal-title":"Curr Opin Colloid Interface Sci"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/152102a0","volume":"152","author":"Hoar T.P.","year":"1943","unstructured":"Hoar T.P.; Schulman J.H.; Transparent water-in-oil dispersions: The oleopathic hydro-micelle. Nature  1943,152(3847),102-103","journal-title":"Nature"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1590\/S0100-40422004000100023","volume":"27","author":"Oliveira A.G.","year":"2004","unstructured":"Oliveira A.G.; Scarpa M.V.; Correa M.A.; Cera L.F.R.; Formariz T.P.; Microemuls\u00f5es: Estrutura e aplica\u00e7\u00f5es como sistema de libera\u00e7\u00e3o de f\u00e1rmacos. Quim Nova  2004,27(1),131-138","journal-title":"Quim Nova"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3109\/08982104.2015.1120746","volume":"26","author":"Mishra R.","year":"2016","unstructured":"Mishra R.; Prabhavalkar K.S.; Bhatt L.K.; Preparation, optimization, and evaluation of Zaltoprofen-loaded microemulsion and microemulsion-based gel for transdermal delivery. J Liposome Res  2016,26(4),297-306","journal-title":"J Liposome Res"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1208\/s12249-016-0667-z","volume":"18","author":"Cao M.","year":"2017","unstructured":"Cao M.; Ren L.; Chen G.; Formulation optimization and ex vivo and in vivo evaluation of celecoxib microemulsion-based gel for transdermal delivery. AAPS PharmSciTech  2017,18(6),1960-1971","journal-title":"AAPS PharmSciTech"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S1473-3099(06)70654-5","volume":"6","author":"Hengge U.R.","year":"2006","unstructured":"Hengge U.R.; Currie B.J.; J\u00e4ger G.; Lupi O.; Schwartz R.A.; Scabies: A ubiquitous neglected skin disease. Lancet Infect Dis  2006,6(12),769-779","journal-title":"Lancet Infect Dis"},{"key":"ref=100","doi-asserted-by":"crossref","first-page":"10006628","DOI":"10.3389\/fnano.2022.1006628","volume":"4","author":"Gupta N.","year":"2022","unstructured":"Gupta N.; Gupta G.; Siingh D.; Localized topical drug delivery systems for skin cancer: Current approaches and future prospects. Front Nanotechnol  2022,4,10006628","journal-title":"Front Nanotechnol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1208\/s12249-019-1374-3","volume":"20","author":"Talaat S.M.","year":"2019","unstructured":"Talaat S.M.; Elnaggar Y.S.R.; Abdalla O.Y.; Lecithin microemulsion lipogels versus conventional gels for skin targeting of terconazole: In vitro, ex vivo, and in vivo investigation. AAPS PharmSciTech  2019,20(4),161","journal-title":"AAPS PharmSciTech"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0378-5173(94)90346-8","volume":"111","author":"Thacharodi D.","year":"1994","unstructured":"Thacharodi D.; Panduranga R.K.; Transdermal absorption of nifedipine from microemulsions of lipophilic skin penetration enhancers. Int J Pharm  1994,111(3),235-240","journal-title":"Int J Pharm"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.2147\/IJN.S250960","volume":"15","author":"Abdellatif M.M.","year":"2020","unstructured":"Abdellatif M.M.; Khalil I.A.; Elakkad Y.E.; Eliwa H.A.; Samir T.; Al-Mokaddem A.K.; Formulation and characterization of sertaconazole nitrate mucoadhesive liposomes for vaginal candidiasis. Int J Nanomedicine  2020,15,4079-4090","journal-title":"Int J Nanomedicine"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3390\/coatings10040304","volume":"10","author":"Zhang L.","year":"2020","unstructured":"Zhang L.; Li X.; Zhu S.; Dermal targeting delivery of terbinafine hydrochloride using novel multi-ethosomes: A new approach to fungal infection treatment. Coatings  2020,10(4),304","journal-title":"Coatings"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s12668-022-00948-4","volume":"12","author":"Singh A.K.","year":"2022","unstructured":"Singh A.K.; Mukerjee A.; Pandey H.; Mishra S.B.; Miconazole nitrate\u2013loaded solid lipid nanoparticle-based hydrogel ameliorate Candida albicans induced mycoses in experimental animals. Bionanoscience  2022,12(2),512-526","journal-title":"Bionanoscience"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"110705","DOI":"10.1016\/j.colsurfb.2019.110705","volume":"186","author":"Carbone C.","year":"2020","unstructured":"Carbone C.; Fuochi V.; Zieli\u0144ska A.; Dual-drugs delivery in solid lipid nanoparticles for the treatment of Candida albicans mycosis. Colloids Surf B Biointerfaces  2020,186,110705","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1007\/s00289-020-03220-5","volume":"78","author":"Sharma M.","year":"2021","unstructured":"Sharma M.; Mundlia J.; Kumar T.; Ahuja M.; A novel microwave-assisted synthesis, characterization and evaluation of luliconazole-loaded solid lipid nanoparticles. Polym Bull  2021,78(5),2553-2567","journal-title":"Polym Bull"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jddst.2019.04.026","volume":"52","author":"Waghule T.","year":"2019","unstructured":"Waghule T.; Rapalli V.K.; Singhvi G.; Voriconazole loaded nanostructured lipid carriers based topical delivery system: QbD based designing, characterization, in vitro and ex vivo evaluation. J Drug Deliv Sci Technol  2019,52,303-315","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s13346-015-0263-x","volume":"6","author":"Singh S.","year":"2016","unstructured":"Singh S.; Singh M.; Tripathi C.B.; Arya M.; Saraf S.A.; Development and evaluation of ultra-small nanostructured lipid carriers: Novel topical delivery system for athlete\u2019s foot. Drug Deliv Transl Res  2016,6(1),38-47","journal-title":"Drug Deliv Transl Res"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"e13959","DOI":"10.1111\/dth.13959","volume":"33","author":"Baghel S.","year":"2020","unstructured":"Baghel S.; Nair V.S.; Pirani A.; Luliconazole\u2010loaded nanostructured lipid carriers for topical treatment of superficial Tinea infections. Dermatol Ther  2020,33(6),e13959","journal-title":"Dermatol Ther"},{"key":"ref=111","first-page":"85","volume":"16","author":"Zafar A.","year":"2020","unstructured":"Zafar A.; Qumber M.; Alruwaili N.; BBD-based development of itraconazole loaded nanostructured lipid carrier for topical delivery: In vitro evaluation and antimicrobial assessment. J Pharm Innov  2020,16,85-98","journal-title":"J Pharm Innov"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.xphs.2019.10.009","volume":"109","author":"Ferreira P.G.","year":"2020","unstructured":"Ferreira P.G.; Noronha L.; Teixeira R.; Investigation of a microemulsion containing clotrimazole and itraconazole for transdermal delivery for the treatment of sporotrichosis. J Pharm Sci  2020,109(2),1026-1034","journal-title":"J Pharm Sci"},{"key":"ref=113","first-page":"54","volume":"13","author":"Samy A.","year":"2018","unstructured":"Samy A.; Ramadan A.A.; El-enin A.S.M.A.; Yasmin I.; In novel proniosomes as drug delivery system for transdermal application of itraconazole:Development, Characterization, clinical and bioavailability study. J Pharm Biol Sci  2018,13(1),54-71","journal-title":"J Pharm Biol Sci"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.2147\/IJN.S206657","volume":"14","author":"Yang Q.","year":"2019","unstructured":"Yang Q.; Liu S.; Gu Y.; Development of sulconazole-loaded nanoemulsions for enhancement of transdermal permeation and antifungal activity. Int J Nanomedicine  2019,14,3955-3966","journal-title":"Int J Nanomedicine"},{"key":"ref=115","unstructured":"Clinical assessment of voriconazole self nano emulsifying drug delivery system intermediate gel. Clinical Trial Gov Available at:  https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04110860?term=voriconazole%2C+self+nano+emulsifyinganddraw=2andrank=1 (accessed 04-11-2022)."},{"key":"ref=116","unstructured":"Clinical assessment of itraconazole self nano emulsifying drug delivery system intermediate gel. Clinical Trial Gov Available at:  https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04110834?term=nct04110834anddraw=2andrank=1 (accessed 04-11-2022)."},{"key":"ref=117","unstructured":"TDT 067 onychomycosis study. tdt 067 onychomycosis study. Clinical Trial Gov Available at:  https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01145807 (accessed 04-11- 2022)."},{"key":"ref=118","unstructured":"Clinical Assessment of Oxiconazole Nitrate Solid Lipid Nanoparticles Loaded Gel. Clinical Trial Gov Available at:  https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03823040 (accessed 04-11-2022)."},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/10717544.2017.1413444","volume":"25","author":"El-Housiny S.","year":"2018","unstructured":"El-Housiny S.; Shams Eldeen M.A.; El-Attar Y.A.; Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: Formulation and clinical study. Drug Deliv  2018,25(1),78-90","journal-title":"Drug Deliv"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1080\/10717544.2022.2067601","volume":"29","author":"Lamie C.","year":"2022","unstructured":"Lamie C.; Elmowafy E.; Ragaie M.H.; Attia D.A.; Mortada N.D.; Assessment of antifungal efficacy of itraconazole loaded aspasomal cream: Comparative clinical study. Drug Deliv  2022,29(1),1345-1357","journal-title":"Drug Deliv"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1080\/10717544.2022.2057619","volume":"29","author":"Albash R.","year":"2022","unstructured":"Albash R.; Ragaie M.H.; Hassab M.A.E.; Fenticonazole nitrate loaded trans-novasomes for effective management of tinea corporis: Design characterization, in silico study, and exploratory clinical appraisal. Drug Deliv  2022,29(1),1100-1111","journal-title":"Drug Deliv"},{"key":"ref=122","unstructured":"Adjunctive Sertraline for the Treatment of HIVAssociated Cryptococcal Meningitis. ClinicalTrials.gov Available at:  https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01802385"},{"key":"ref=123","unstructured":"Clinical Study of AK1820 (Isavuconazonium Sulfate) for the Treatment of Deep Mycosis. ClinicalTrials.gov Available at:  https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03471988"},{"key":"ref=124","unstructured":"Pharmacokinetics and Safety of Intravenous Posaconazole (MK-5592) in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-120). ClinicalTrials.gov Available at:  https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03336502"},{"key":"ref=125","unstructured":"Endemic Mycoses Treatment With SUBAitraconazole vs Itraconazole (MSG15). ClinicalTrials.gov Available at:  https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03572049"},{"key":"ref=126","unstructured":"Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of Mycoses. ClinicalTrials.gov Available at:  https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00722189"},{"key":"ref=127","author":"Young-wook Choi","year":"2012","unstructured":"Young-wook Choi; Chil-hwan Oh; Kyung-ho Kang; Cell penetrating peptide modified nanoliposome and anti-atopic composition comprising the same. KP 101130550B1,  2012","journal-title":"KP 101130550B1,"},{"key":"ref=128","author":"Orza A.","year":"2020","unstructured":"Orza A.; Method for preparing ph dependent ultra small polymeric nanoparticles for topical and\/or transdermal delivery. US 10850246B2,  2020","journal-title":"US 10850246B2,"},{"key":"ref=129","author":"Gary Van Nest ST","year":"2014","unstructured":"Gary Van Nest ST; Karen L; Dino Dina Biodegradable immunomodulatory formulations and methods for use there of. US 8669237B2,  2014","journal-title":"US 8669237B2,"},{"key":"ref=130","author":"Anita Shukla SC","year":"2022","unstructured":"Anita Shukla SC; Eli silvert antifungal nanoparticles for targeted treatment of fungal infections. US 011273124B2,  2022","journal-title":"US 011273124B2,"},{"key":"ref=131","author":"Stephen W.","year":"2019","unstructured":"Stephen W.; Antimicrobial and antifungal polymer fibers, fabrics, and methods of manufacture thereof. US 010508188B2,  2019","journal-title":"US 010508188B2,"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1021\/acsnano.0c00173","volume":"14","author":"Chariou P.L.","year":"2020","unstructured":"Chariou P.L.; Ortega-Rivera O.A.; Steinmetz N.F.; Nanocarriers for the delivery of medical, veterinary, and agricultural active ingredients. ACS Nano  2020,14(3),2678-2701","journal-title":"ACS Nano"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"e1416","DOI":"10.1002\/wnan.1416","volume":"9","author":"Caster J.M.","year":"2017","unstructured":"Caster J.M.; Patel A.N.; Zhang T.; Wang A.; Investigational nanomedicines in 2016: A review of nanotherapeutics currently undergoing clinical trials. Wiley Interdiscip Rev Nanomed Nanobiotechnol  2017,9(1),e1416","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s13346-013-0129-z","volume":"3","author":"Shen J.","year":"2013","unstructured":"Shen J.; Burgess D.J.; In vitro dissolution testing strategies for nanoparticulate drug delivery systems: Recent developments and challenges. Drug Deliv Transl Res  2013,3(5),409-415","journal-title":"Drug Deliv Transl Res"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11051-019-4498-1","volume":"21","author":"Larsson S.","year":"2019","unstructured":"Larsson S.; Jansson M.; Boholm \u00c5.; Expert stakeholders\u2019 perception of nanotechnology: Risk, benefit, knowledge, and regulation. J Nanopart Res  2019,21(3),57","journal-title":"J Nanopart Res"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v18.i5.10","volume":"18","author":"Bussemer T.","year":"2001","unstructured":"Bussemer T.; Otto I.; Bodmeier R.; Pulsatile drug-delivery systems. Crit Rev Ther Drug Carrier Syst  2001,18(5),26","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2010.07.026","volume":"398","author":"Maroni A.","year":"2010","unstructured":"Maroni A.; Zema L.; Curto M.D.D.; Loreti G.; Gazzaniga A.; Oral pulsatile delivery: Rationale and chronopharmaceutical formulations. Int J Pharm  2010,398(1-2),1-8","journal-title":"Int J Pharm"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s11095-006-9906-4","volume":"23","author":"Staples M.","year":"2006","unstructured":"Staples M.; Daniel K.; Cima M.J.; Langer R.; Application of micro- and nano-electromechanical devices to drug delivery. Pharm Res  2006,23(5),847-863","journal-title":"Pharm Res"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10717544.2014.903579","volume":"23","author":"Sutradhar K.B.","year":"2016","unstructured":"Sutradhar K.B.; Sumi C.D.; Implantable microchip: The futuristic controlled drug delivery system. Drug Deliv  2016,23(1),1-11","journal-title":"Drug Deliv"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jconrel.2021.08.030","volume":"338","author":"Wang W.","year":"2021","unstructured":"Wang W.; Ye Z.; Gao H.; Ouyang D.; Computational pharmaceutics: A new paradigm of drug delivery. J Control Release  2021,338,119-136","journal-title":"J Control Release"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jconrel.2019.08.030","volume":"311-312","author":"Han R.","year":"2019","unstructured":"Han R.; Xiong H.; Ye Z.; Predicting physical stability of solid dispersions by machine learning techniques. J Control Release  2019,311-312,16-25","journal-title":"J Control Release"},{"key":"ref=142","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fmats.2015.00064","volume":"2","author":"Thota N.","year":"2015","unstructured":"Thota N.; Jiang J.; Computat cional amphiphilic materials for drug delivery. Front Mater  2015,2,64","journal-title":"Front Mater"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.nano.2011.05.006","volume":"8","author":"Huynh L.","year":"2012","unstructured":"Huynh L.; Neale C.; Pom\u00e8s R.; Allen C.; Computational approaches to the rational design of nanoemulsions, polymeric micelles, and dendrimers for drug delivery. Nanomedicine  2012,8(1),20-36","journal-title":"Nanomedicine"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jconrel.2020.03.043","volume":"322","author":"He Y.","year":"2020","unstructured":"He Y.; Ye Z.; Liu X.; Can machine learning predict drug nanocrystals? J Control Release  2020,322,274-285","journal-title":"J Control Release"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s13346-021-00929-2","volume":"11","author":"Egorov E.","year":"2021","unstructured":"Egorov E.; Pieters C.; Korach-Rechtman H.; Shklover J.; Schroeder A.; Robotics, microfluidics, nanotechnology and AI in the synthesis and evaluation of liposomes and polymeric drug delivery systems. Drug Deliv Transl Res  2021,11(2),345-352","journal-title":"Drug Deliv Transl Res"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"e1554","DOI":"10.1002\/wnan.1554","volume":"11","author":"Duarte Y.","year":"2019","unstructured":"Duarte Y.; M\u00e1rquez-Miranda V.; Miossec M.J.; Gonz\u00e1lez-Nilo F.; Integration of target discovery, drug discovery and drug delivery: A review on computational strategies. Wiley Interdiscip Rev Nanomed Nanobiotechnol  2019,11(4),e1554","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2006.09.011","volume":"66","author":"Maas J.","year":"2007","unstructured":"Maas J.; Kamm W.; Hauck G.; An integrated early formulation strategy: From hit evaluation to preclinical candidate profiling. Eur J Pharm Biopharm  2007,66(1),1-10","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"49a","DOI":"10.1016\/j.bpj.2008.12.151","volume":"96","author":"Gonzalez-Ibanez A.M.","year":"2009","unstructured":"Gonzalez-Ibanez A.M.; Gonzalez-Nilo F.; Cachau R.; The collaboratory for structural nanobiology. Biophys J  2009,96(3),49a","journal-title":"Biophys J"},{"key":"ref=149","first-page":"7","volume":"8","author":"Ostraat M.L.","year":"2013","unstructured":"Ostraat M.L.; Mills K.C.; Guzan K.A.; Murry D.; The nanomaterial registry: Facilitating the sharing and analysis of data in the diverse nanomaterial community. Int J Nanomedicine  2013,8(1),7-13","journal-title":"Int J Nanomedicine"}],"container-title":["Recent Patents on Nanotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1872210517666230727090314","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/219162\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1872210517666230727090314","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T12:32:09Z","timestamp":1744115529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/219162\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":149,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1872210517666230727090314","relation":{},"ISSN":["1872-2105"],"issn-type":[{"value":"1872-2105","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-03-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}